sun13837
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2012 (NCT01502631)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
FGFR1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sun13837
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02258880 | Phase 2 | Sep 1, 2014 | Daiichi Sankyo, INC Research |
| NCT01502631 | Phase 2 | Jan 1, 2012 | Daiichi Sankyo |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daiichi Sankyo | For profit | 2 | 2 | 1 | 2012 |
| INC Research | For profit | 1 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1